DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.

Information source: Nobelpharma
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Wison's Disease

Intervention: Zinc acetate (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Nobelpharma

Official(s) and/or principal investigator(s):
Koudou Ishii, M.D., Study Director, Affiliation: National MINAMIYOKOHAMA Hospital

Summary

The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.

Clinical Details

Official title: Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.

Study design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Eligibility

Minimum age: 1 Year. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Wilson's disease(adult,infant,pregnant woman)

Exclusion Criteria:

- acute hepatitis

- malignant tumor

Locations and Contacts

Additional Information

Starting date: October 2004
Last updated: September 9, 2010

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017